Michael Daughton Acquires 10,167 Shares of TruBridge (NASDAQ:TBRG) Stock

TruBridge, Inc. (NASDAQ:TBRG) insider Michael Daughton purchased 10,167 shares of the business’s stock in a transaction dated Wednesday, November 12th. The shares were acquired at an average price of $19.95 per share, for a total transaction of $202,831.65. Following the acquisition, the insider owned 33,138 shares of the company’s stock, valued at $661,103.10. This trade represents a 44.26% increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Michael Daughton also recently made the following trade(s):

• On Monday, November 17th, Michael Daughton acquired 17,500 shares of TruBridge stock. The stock was bought at an average cost of $20.46 per share, for a total transaction of $358,050.00.
• On Friday, November 14th, Michael Daughton purchased 2,500 shares of TruBridge stock. The stock was purchased at an average price of $20.15 per share, for a total transaction of $50,375.00.
• On Thursday, November 13th, Michael Daughton bought 4,354 shares of TruBridge stock. The stock was purchased at an average price of $20.16 per share, for a total transaction of $87,776.64.
• On Tuesday, November 11th, Michael Daughton bought 15,479 shares of TruBridge stock. The shares were acquired at an average price of $19.39 per share, for a total transaction of $300,137.81.

TruBridge Price Performance

TruBridge stock opened at $20.61 on Thursday. The stock has a market capitalization of $309.34 million, a price-to-earnings ratio of -24.54 and a beta of 0.57. TruBridge, Inc. has a 52-week low of $15.69 and a 52-week high of $32.00. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.79 and a current ratio of 1.80. The stock’s 50 day moving average price is $20.15 and its two-hundred day moving average price is $21.60.

TruBridge (NASDAQ:TBRG) last issued its earnings results on Thursday, November 6th. The company reported $0.88 EPS for the quarter, beating the consensus estimate of $0.40 by $0.48. The company had revenue of $86.11 million during the quarter, compared to the consensus estimate of $85.56 million. TruBridge had a positive return on equity of 3.30% and a negative net margin of 3.63%. TruBridge has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. On average, equities analysts predict that TruBridge, Inc. will post 0.07 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on TBRG shares. BMO Capital Markets began coverage on shares of TruBridge in a research report on Thursday, November 13th. They set a “market perform” rating and a $19.50 target price on the stock. Weiss Ratings reissued a “sell (e+)” rating on shares of TruBridge in a research report on Friday, October 31st. One research analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $25.50.

Institutional Investors Weigh In On TruBridge

Hedge funds and other institutional investors have recently bought and sold shares of the business. Legal & General Group Plc bought a new position in TruBridge in the 2nd quarter worth about $26,000. First Horizon Corp purchased a new stake in shares of TruBridge in the third quarter worth about $42,000. Police & Firemen s Retirement System of New Jersey bought a new position in shares of TruBridge in the second quarter valued at approximately $59,000. New York State Common Retirement Fund purchased a new position in TruBridge during the second quarter valued at approximately $101,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new position in TruBridge during the second quarter valued at approximately $128,000. Institutional investors own 88.64% of the company’s stock.

About TruBridge

TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.